2 февр. 2024 г. · U.S. Humira net revenues were $2.740 billion , a decrease of 45.3 percent. Internationally, Humira net revenues were $564 million , a decrease ...

12 июл. 2024 г. · Last year, Humira sales fell to $14.4 billion after a record $21.2 billion during the prior year.

25 июл. 2024 г. · According to an analyst report from Guggenheim Securities, the company's total net revenue was $14.46 billion, an increase of 4.3% from Q2 2023.

5 февр. 2024 г. · AbbVie has reported a decrease in net revenues to $54.32bn for the year ended 31 December 2023, marking a 6.4% decline from the previous year's $58.05bn.

2 февр. 2024 г. · During the final quarter of 2023, sales of Humira—which once sat pretty as the world's best-selling drug—plunged nearly 41% to $3.3 billion ...

24 мая 2024 г. · From its 2002 US Food and Drug Administration approval to 2023, Humira generated $187 billion for AbbVie. This monoclonal antibody has been ...

22 мая 2024 г. · In 2023, once again, the company's top revenue generating drug was Humira. In that year, Humira generated about 14.4 billion US dollars in revenue for AbbVie.

30 мая 2024 г. · The top selling drug of 2023 generated $25 billion in revenue in 2023. ... 02: Humira — $14.4 billion. Image for article titled Ozempic ...

12 июл. 2024 г. · In 2023, suffering growing biosimilar erosion, Humira's global sales dipped 32% to $14.4 billion. Humira biosimilars first entered the U.S. ...